アリゾナ州における肺がんの臨床試験
アリゾナ州内の拠点で、肺がんに関する34件の研究が参加者を募集しています。
アリゾナ州内の都市
公式研究テキスト（英語）
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
- Banner Boswell Medical Center, Sun City
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/02更新 · NCT04267848Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Kingman Regional Medical Center, Kingman
- Cancer Center at Saint Joseph's, Phoenix
被験者募集中観察研究健康なボランティア歓迎
40歳〜75歳 · 全性別 · 2026/10/02更新 · NCT05334069Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
- Cancer Center at Saint Joseph's, Phoenix
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/01更新 · NCT04181060Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
- Palo Verde Hematology Oncology, Glendale
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/30更新 · NCT06765109Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Pioneer Research Center, Bullhead City
- Ironwood Cancer & Research Centers, Chandler
- Ironwood Cancer & Research Centers, Gilbert
- 他6件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07222566Fucoidan for Preventing Chemotherapy-Related Fatigue in Patients With Gastrointestinal, Gynecological, Breast, or Lung Cancer
- Mayo Clinic in Arizona, Scottsdale
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06855524A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
- Cancer Treatment Centers of America, Phoenix, Goodyear
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07154290A Registry for People With Lung Cancer
- University of Arizona (Data Collection Only), Tucson
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/24更新 · NCT06424327A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
- Mayo Clinic in Arizona - Phoenix, Phoenix
- University of Arizona Cancer Center, Tucson
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/23更新 · NCT07063745Social Optimization Study
- University of Arizona Mel and Enid Zuckerman College of Public Health, Tucson
被験者募集中
18歳〜99歳 · 全性別 · 2026/09/21更新 · NCT07564960RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial
- Dr. Amit Kulkarni, Phoenix
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/17更新 · NCT04105270Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Banner Health- MD Anderson Cancer Center, Gilbert
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/16更新 · NCT05786924A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
- City of Hope - Phoenix, Goodyear
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/08更新 · NCT06793215A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Banner MD Anderson Cancer Center, Gilbert
- Banner University Medical Center Phoenix, Phoenix
- The University of Arizona Cancer Center - North Campus, Tucson
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/08更新 · NCT06119581A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
- HonorHealth, Scottsdale
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/04更新 · NCT06400472AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
- Avenzo Therapeutics Recruiting Site, Gilbert
被験者募集中第1/2相
18歳〜75歳 · 全性別 · 2026/09/04更新 · NCT07038343Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
- ACRC Arizona Clinical Research Center, Tucson
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/01更新 · NCT06712355Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
- Mayo Clinic Hospital in Arizona, Phoenix
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/17更新 · NCT06500481Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
- Kingman Regional Medical Center, Kingman
- Cancer Center at Saint Joseph's, Phoenix
- Mayo Clinic Hospital in Arizona, Phoenix
- 他2件
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/17更新 · NCT05624996Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
- Xencor Investigative Site, Phoenix
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/03更新 · NCT05433142Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
- Banner MD Anderson Cancer Center, Gilbert
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/06/30更新 · NCT06162221Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
- Banner Health MD Anderson, Gilbert
被験者募集中第2相
18歳〜70歳 · 全性別 · 2026/06/26更新 · NCT04614103A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
- Banner Health, Gilbert
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/06/12更新 · NCT06051695Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
- Kingman Regional Medical Center, Kingman
被験者募集中第2相
18歳以上 · 全性別 · 2026/06/03更新 · NCT05642572MYLUNG Consortium Part 3: Observational Study
- Arizona Oncology Associates, PC - NAHOA, Prescott Valley
被験者募集中観察研究
18歳以上 · 全性別 · 2026/05/18更新 · NCT05885698Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
- Mayo Clinic Scottsdale, Scottsdale
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/05/14更新 · NCT06922591Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
- Banner University Medical Center - Tucson, Tucson
- University of Arizona Cancer Center-North Campus, Tucson
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/05/05更新 · NCT06616584The Impact of Exercise on the Tumor Microenvironment in Patients With Lung Cancer
- University of Arizona Cancer Center, Tucson
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2026/04/21更新 · NCT07216209Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial
- CTCA at Western Regional Medical Center, Goodyear
被験者募集中第2相
18歳以上 · 全性別 · 2026/04/15更新 · NCT07288034Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- Mayo Clinic Scottsdale, Scottsdale
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/04/13更新 · NCT06810544A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
- HonorHealth Research Institute, Scottsdale
- The University of Arizona Cancer Center, Tucson
被験者募集中第1相
18歳以上 · 全性別 · 2026/02/13更新 · NCT06778863SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Scottsdale
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs
- HonorHealth Research Institute, Scottsdale
被験者募集中第1/2相
18歳以上 · 全性別 · 2025/10/24更新 · NCT06228326A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
- Banner MD Anderson Cancer Center, Gilbert
被験者募集中第1/2相
18歳以上 · 全性別 · 2025/09/09更新 · NCT06682793ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。